Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 273 No 7309 p128
24 July 2004


Society summary


Pass rate of 91.3pc in Society's summer registration examination

The pass rate in the Royal Pharmaceutical Society's summer registration examination this year is 91.3 per cent. The number of candidates was 1,498, of whom 1,367 were successful (PDF 100K).

The examination was the third to be held following the introduction of a revised syllabus and a new format. In 2003 the number of candidates was 1,537 and the pass rate was 82.4 per cent. In the separate section of calculation questions, which candidates have to pass in addition to passing the examination as a whole, 1,403 candidates (93.7 per cent) of candidates were successful compared with 91.9 per cent in 2003.

The mean percentage scores for the different components of the examination were as follows: overall 84 (range 52–99); closed book 86 (range 53–100); open book 83 (range 41–100); calculations 86 (range 25–100).

The mean percentage scores for the individual syllabus sections were as follows: Section 1 (professional and legal practice) — part I (professional practice of a pharmacy) 86, part II (legal aspects of providing a pharmaceutical service) 85; section 2 (clinical and pharmaceutical practice) — part I (clinical practice) 84, part II (pharmaceutical aspects of practice) 85; section 3 (systems and procedures) 82.

Of this year’s 1,498 candidates, 1,427 were UK graduates or sandwich course students, of whom 1,309 (91.7 per cent) passed and 118 (8.3 per cent) failed. The remaining 71 candidates were pharmacists from overseas seeking to register through the adjudicating route. Of these, 58 (81.7 per cent) passed and 13 (18.3 per cent) failed.

For 115 of the 131 candidates who failed, this examination was their first attempt. For 13 of these candidates it was the second attempt, and for three it was their third and final attempt.

The next sitting of the examination takes place on Friday 24 September.


Pass list, p131

Back to Top


©The Pharmaceutical Journal